A Rare Case of Dedifferentiated Retroperitoneal Liposarcoma Presenting As Cardiac-Sounding Chest Pain

被引:0
作者
Manku, Bhagat [1 ]
Addingadoo, Parvati [2 ]
Ali, Amjad [2 ]
机构
[1] Univ Hosp Coventry & Warwickshire, Med Educ, Coventry, W Midlands, England
[2] Univ Hosp Coventry & Warwickshire, Med, Coventry, W Midlands, England
关键词
retroperitoneal liposarcoma; dedifferentiated liposarcoma; mesenchymal tumors; chemotherapy; mdm2; SOFT-TISSUE SARCOMA;
D O I
10.7759/cureus.19503
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Retroperitoneal liposarcomas (RPL) are rare mesenchymal tumours with an annual incidence of 2.7 cases per million. Well-differentiated liposarcomas (WDLs) and dedifferentiated liposarcomas (DDLs) are the most common subtype. WDLs are widely known to be low-grade tumours that are less likely to metastasise and easily resected. In contrast, DDLs are high-grade aggressive metastatic tumours with mortality rates between 50% and 70%. We present an unusual case of a 47-year-old male with a background of hypertension presenting with cardiac-sounding chest pain. Initially managed as an acute coronary syndrome (ACS), he eventually underwent a CT scan which revealed a 20x18x17cm retroperitoneal complex mass with possible infiltrates to the posterior wall of the greater curvature of the stomach. Ultrasound-guided biopsy and subsequent histopathology analysis revealed DDLs consistent with MDM2 amplification. This case highlights how RPLs can present with diagnostic difficulties. Multidisciplinary input from haematology, surgery and specialist teams is vital to optimise patient management.
引用
收藏
页数:5
相关论文
共 21 条
[1]   MDM2 inhibition in liposarcoma: a step in the right direction [J].
Constantinidou, Anastasia ;
Pollack, Seth M. ;
Jones, Robin L. .
LANCET ONCOLOGY, 2012, 13 (11) :1070-1071
[2]  
Conyers Rachel, 2011, Sarcoma, V2011, P483154, DOI 10.1155/2011/483154
[3]   Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma [J].
Crago, Aimee M. ;
Singer, Samuel .
CURRENT OPINION IN ONCOLOGY, 2011, 23 (04) :373-378
[4]   Complete Remission of Recurrent Retroperitoneal Liposarcoma after the Administration of Gemcitabine and Docetaxel as First-Line Adjuvant Chemotherapy: A Case Report [J].
Da Silva, Filipe Rocha ;
Jeronimo Lima, Alan Vitor ;
Rocha Pereira Albuquerque, Erick Willian ;
Moreira-Silva, Carlos Augusto ;
Flexa De Oliveira, Nicole Maues ;
Langbeck Ohana, Jorge Alberto ;
Werneck Carvalho, Luis Eduardo .
CASE REPORTS IN ONCOLOGY, 2018, 11 (02) :341-346
[5]   Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience [J].
de Vreeze, Ronald S. A. ;
de Jong, Daphne ;
Nederlof, Petra M. ;
Ariaens, Aafke ;
Tielen, Ivon H. G. ;
Frenken, Luc ;
Haas, Rick L. ;
van Coevorden, Frits .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (03) :686-693
[6]   Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma [J].
Dickson, Mark A. ;
Tap, William D. ;
Keohan, Mary Louise ;
D'Angelo, Sandra P. ;
Gounder, Mrinal M. ;
Antonescu, Cristina R. ;
Landa, Jonathan ;
Qin, Li-Xuan ;
Rathbone, Dustin D. ;
Condy, Mercedes M. ;
Ustoyev, Yelena ;
Crago, Aimee M. ;
Singer, Samuel ;
Schwartz, Gary K. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (16) :2024-+
[7]   Dedifferentiated Liposarcoma: Systemic Therapy Options [J].
Gahvari, Zhubin ;
Parkes, Amanda .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (02)
[8]   Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations [J].
In, Gino K. ;
Hu, James S. ;
Tseng, William W. .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (08) :533-550
[9]  
Keung E.Z., 2019, J. Transl. Genet. Genomics, V3, DOI DOI 10.20517/JTGG.2019.03
[10]   Retroperitoneal soft-tissue sarcoma - Analysis of 500 patients treated and followed at a single institution [J].
Lewis, JJ ;
Leung, D ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 1998, 228 (03) :355-363